These findings suggest that over-activated mTOR under T2DM or HG conditions contributes to higher phosphorylated TFEB levels, which in turn reduces TFEB levels in the nucleus and inhibits ALP function. The gene discussed is MTOR; the disease is type 2 diabetes mellitus.